Skip to main content
Top
Published in: Diabetologia 4/2008

01-04-2008 | Article

A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians

Authors: K. S. Park, J. C. Chan, L.-M. Chuang, S. Suzuki, E. Araki, K. Nanjo, L. Ji, M. Ng, M. Nishi, H. Furuta, T. Shirotani, B. Y. Ahn, S. S. Chung, H.-K. Min, S. W. Lee, J. H. Kim, Y. M. Cho, H. K. Lee, for The Study Group of Molecular Diabetology in Asia

Published in: Diabetologia | Issue 4/2008

Login to get access

Abstract

Aims/hypothesis

This multinational study was conducted to investigate the association between a mitochondrial DNA (mtDNA) T16189C polymorphism and type 2 diabetes in Asians. The mtDNA 16189C variant has been reported to be associated with insulin resistance and type 2 diabetes. However, a recent meta-analysis concluded that it is negatively associated with type 2 diabetes in Europids. Since the phenotype of an mtDNA mutant may be influenced by environmental factors and ethnic differences in the nuclear and mitochondrial genomes, we investigated the association between the 16189C variant and type 2 diabetes in Asians.

Methods

The presence of the mtDNA 16189C variant was determined in 2,469 patients with type 2 diabetes and 1,205 non-diabetic individuals from Korea, Japan, Taiwan, Hong Kong and China. An additional meta-analysis including previously published Asian studies was performed. Since mtDNA nucleotide position 16189 is very close to the mtDNA origin of replication, we performed DNA-linked affinity chromatography and reverse-phase liquid chromatography/tandem mass spectrometry and chromatin immunoprecipitation to identify protein bound to the 16189 region.

Results

Analysis of participants from five Asian countries confirmed the association between the 16189C variant and type 2 diabetes [odds ratio (OR) 1.256, 95% CI 1.08–1.46, p = 0.003]. Inclusion of data from three previously published Asian studies (type 2 diabetes n = 3,283, controls n = 2,176) in a meta-analysis showed similar results (OR 1.335, 95% CI 1.18–1.51, p = 0.000003). Mitochondrial single-stranded DNA-binding protein (mtSSB) was identified as a candidate protein bound to the 16189 region. Chromatin immunoprecipitation in cybrid cells showed that mtSSB has a lower binding affinity for the 16189C variant than the wild-type sequence.

Conclusions/interpretation

The mtDNA 16189C variant is associated with an increased risk of type 2 diabetes in Asians.
Appendix
Available only for authorised users
Literature
1.
go back to reference Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedCrossRef Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedCrossRef
2.
go back to reference Maassen JA, ‘t Hart LM, Van Essen E et al (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1):S103–S109PubMedCrossRef Maassen JA, ‘t Hart LM, Van Essen E et al (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1):S103–S109PubMedCrossRef
3.
go back to reference Wilson FH, Hariri A, Farhi A et al (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306:1190–1194PubMedCrossRef Wilson FH, Hariri A, Farhi A et al (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306:1190–1194PubMedCrossRef
4.
go back to reference Poulton J, Brown MS, Cooper A, Marchington DR, Phillips DI (1998) A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 41:54–58PubMedCrossRef Poulton J, Brown MS, Cooper A, Marchington DR, Phillips DI (1998) A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 41:54–58PubMedCrossRef
5.
go back to reference Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ (2002) Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 11:1581–1583PubMedCrossRef Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ (2002) Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 11:1581–1583PubMedCrossRef
6.
go back to reference Kim JH, Park KS, Cho YM et al (2002) The prevalence of the mitochondrial DNA 16189 variant in non-diabetic Korean adults and its association with higher fasting glucose and body mass index. Diabet Med 19:681–684PubMedCrossRef Kim JH, Park KS, Cho YM et al (2002) The prevalence of the mitochondrial DNA 16189 variant in non-diabetic Korean adults and its association with higher fasting glucose and body mass index. Diabet Med 19:681–684PubMedCrossRef
7.
go back to reference Tang DL, Zhou X, Li X, Zhao L, Liu F (2006) Variation of mitochondrial gene and the association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 73:77–82PubMedCrossRef Tang DL, Zhou X, Li X, Zhao L, Liu F (2006) Variation of mitochondrial gene and the association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 73:77–82PubMedCrossRef
8.
go back to reference Momiyama Y, Furutani M, Suzuki Y et al (2003) A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes. Biochem Biophys Res Commun 312:858–864PubMedCrossRef Momiyama Y, Furutani M, Suzuki Y et al (2003) A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes. Biochem Biophys Res Commun 312:858–864PubMedCrossRef
9.
go back to reference Liou CW, Lin TK, Huei Weng H et al (2007) A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: additive effects of genetic and environmental factors. J Clin Endocrinol Metab 92:235–239PubMedCrossRef Liou CW, Lin TK, Huei Weng H et al (2007) A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: additive effects of genetic and environmental factors. J Clin Endocrinol Metab 92:235–239PubMedCrossRef
10.
go back to reference Chinnery PF, Elliott HR, Patel S et al (2005) Role of the mitochondrial DNA 16184–16193 poly-C tract in type 2 diabetes. Lancet 366:1650–1651PubMedCrossRef Chinnery PF, Elliott HR, Patel S et al (2005) Role of the mitochondrial DNA 16184–16193 poly-C tract in type 2 diabetes. Lancet 366:1650–1651PubMedCrossRef
11.
go back to reference Tanaka M, Cabrera VM, Gonzalez AM et al (2004) Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res 14:1832–1850PubMedCrossRef Tanaka M, Cabrera VM, Gonzalez AM et al (2004) Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res 14:1832–1850PubMedCrossRef
12.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef
13.
go back to reference Choi YS, Ryu BK, Min HK, Lee SW, Pak YK (2005) Analysis of proteome bound to D-loop region of mitochondrial DNA by DNA-linked affinity chromatography and reverse-phase liquid chromatography/tandem mass spectrometry. Ann N Y Acad Sci 1042:88–100PubMedCrossRef Choi YS, Ryu BK, Min HK, Lee SW, Pak YK (2005) Analysis of proteome bound to D-loop region of mitochondrial DNA by DNA-linked affinity chromatography and reverse-phase liquid chromatography/tandem mass spectrometry. Ann N Y Acad Sci 1042:88–100PubMedCrossRef
14.
go back to reference Kim M-S, Choie W-S, Shin YS, Yu M-H, Lee S-W (2004) Development of ultra-high pressure capillary reverse-phase liquid chromatography/tandem mass spectrometry for high-sensitive and high-throughput proteomics. Bull Korean Chem Soc 25:1833–1839CrossRef Kim M-S, Choie W-S, Shin YS, Yu M-H, Lee S-W (2004) Development of ultra-high pressure capillary reverse-phase liquid chromatography/tandem mass spectrometry for high-sensitive and high-throughput proteomics. Bull Korean Chem Soc 25:1833–1839CrossRef
15.
go back to reference Chomyn A (1996) Platelet-mediated transformation of human mitochondrial DNA-less cells. Methods Enzymol 264:334–339PubMedCrossRef Chomyn A (1996) Platelet-mediated transformation of human mitochondrial DNA-less cells. Methods Enzymol 264:334–339PubMedCrossRef
16.
go back to reference Orlando V (2000) Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99–104PubMedCrossRef Orlando V (2000) Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99–104PubMedCrossRef
17.
go back to reference Borenstein MHL, Higgins J, Rothstein H (2005) Comprehensive meta-analysis, version 2. Biostat, Englewood Borenstein MHL, Higgins J, Rothstein H (2005) Comprehensive meta-analysis, version 2. Biostat, Englewood
18.
go back to reference Hatchell EC, Colley SM, Beveridge DJ et al (2006) SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Mol Cell 22:657–668PubMedCrossRef Hatchell EC, Colley SM, Beveridge DJ et al (2006) SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Mol Cell 22:657–668PubMedCrossRef
19.
go back to reference Takamatsu C, Umeda S, Ohsato T et al (2002) Regulation of mitochondrial D-loops by transcription factor A and single-stranded DNA-binding protein. EMBO Rep 3:451–456PubMedCrossRef Takamatsu C, Umeda S, Ohsato T et al (2002) Regulation of mitochondrial D-loops by transcription factor A and single-stranded DNA-binding protein. EMBO Rep 3:451–456PubMedCrossRef
20.
go back to reference Yasukawa T, Yang MY, Jacobs HT, Holt IJ (2005) A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA. Mol Cell 18:651–662PubMedCrossRef Yasukawa T, Yang MY, Jacobs HT, Holt IJ (2005) A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA. Mol Cell 18:651–662PubMedCrossRef
21.
go back to reference Cho YM, Park KS, Lee HK (2007) Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Res Clin Pract 77(Suppl 1):S172–S177PubMedCrossRef Cho YM, Park KS, Lee HK (2007) Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Res Clin Pract 77(Suppl 1):S172–S177PubMedCrossRef
22.
go back to reference Pravenec M, Hyakukoku M, Houstek J et al (2007) Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res 17:1319–1326PubMedCrossRef Pravenec M, Hyakukoku M, Houstek J et al (2007) Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res 17:1319–1326PubMedCrossRef
23.
go back to reference Fish J, Raule N, Attardi G (2004) Discovery of a major D-loop replication origin reveals two modes of human mtDNA synthesis. Science 306:2098–2101PubMedCrossRef Fish J, Raule N, Attardi G (2004) Discovery of a major D-loop replication origin reveals two modes of human mtDNA synthesis. Science 306:2098–2101PubMedCrossRef
24.
go back to reference Fuku N, Park KS, Yamada Y et al (2007) Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet 80:407–415PubMedCrossRef Fuku N, Park KS, Yamada Y et al (2007) Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet 80:407–415PubMedCrossRef
25.
go back to reference Brown MD, Starikovskaya E, Derbeneva O et al (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130–138PubMedCrossRef Brown MD, Starikovskaya E, Derbeneva O et al (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130–138PubMedCrossRef
26.
go back to reference Malik S, Sudoyo H, Pramoonjago P et al (2002) Nuclear mitochondrial interplay in the modulation of the homopolymeric tract length heteroplasmy in the control (D-loop) region of the mitochondrial DNA. Hum Genet 110:402–411PubMedCrossRef Malik S, Sudoyo H, Pramoonjago P et al (2002) Nuclear mitochondrial interplay in the modulation of the homopolymeric tract length heteroplasmy in the control (D-loop) region of the mitochondrial DNA. Hum Genet 110:402–411PubMedCrossRef
27.
Metadata
Title
A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians
Authors
K. S. Park
J. C. Chan
L.-M. Chuang
S. Suzuki
E. Araki
K. Nanjo
L. Ji
M. Ng
M. Nishi
H. Furuta
T. Shirotani
B. Y. Ahn
S. S. Chung
H.-K. Min
S. W. Lee
J. H. Kim
Y. M. Cho
H. K. Lee
for The Study Group of Molecular Diabetology in Asia
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0933-z

Other articles of this Issue 4/2008

Diabetologia 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.